netFormulary NHS
North East and North Cumbria
ICS Formulary
 Search
 Recent Updates - Updated items

All Formulary Amendments

  Records 1 to 26 of 26


Details
UPD Published from Draft Mode
10/10/2023 16:15:55
(LoweryM )
UPD sitematrix Changed from 0 to
10/10/2023 16:15:49
(LoweryM )
UPD Ibrutinib (Imbruvica®) approved
10/10/2023 16:15:49
(LoweryM )
LDL Link Added : NICE TA891: Ibrutinib with venetoclax for untreated chronic lymphocytic leukaemia : https://www.nice.org.uk/guidance/ta891
10/10/2023 14:30:51
(DavidS )
UPD sitematrix Changed from 0 to
10/10/2023 14:30:31
(DavidS )
UPD isDraft Changed from N to Y
10/10/2023 14:30:31
(DavidS )
UPD FurtherInformation Changed from
10/10/2023 14:30:31
(DavidS )
UPD Ibrutinib (Imbruvica®) NICE TA891
10/10/2023 14:30:31
(DavidS )
UPD sitematrix Changed from 0 to
11/07/2023 18:25:49
(dmcdermott )
UPD FurtherInformation Changed from
11/07/2023 18:25:49
(dmcdermott )
UPD Ibrutinib (Imbruvica®) =
11/07/2023 18:25:49
(dmcdermott )
LDL Link Added : MHRA Drug Safety Update (August 2017): Ibrutinib (Imbruvica▼): reports of ventricular tachyarrhythmia; risk of hepatitis B reactivation and of opportunistic infections : https://www.gov.uk/drug-safety-update/ibrutinib-imbruvica-reports-
11/07/2023 18:23:28
(dmcdermott )
LDL Link Added : NICE TA795: Ibrutinib for treating Waldenstrom’s macroglobulinaemia : https://www.nice.org.uk/guidance/ta795
06/07/2023 10:59:54
(rpaylor )
LDL Link Added : NICE TA502: Ibrutinib for treating relapsed or refractory mantle cell lymphoma : https://www.nice.org.uk/guidance/ta502
30/07/2018 14:16:41
(DavidS )
UPD Ibrutinib (Imbruvica®) updated additonal information for NICE TA502
30/07/2018 14:16:12
(DavidS )
UPD Published from Draft Mode
09/05/2018 11:38:42
(LoweryM )
UPD Ibrutinib (Imbruvica®) approved
09/05/2018 11:19:31
(LoweryM )
UPD Ibrutinib (Imbruvica®) NICE TA501 approved by APC (April 2018)
27/04/2018 12:54:56
(DavidS )
UPD Ibrutinib (Imbruvica®) approved
11/08/2017 15:29:16
(LoweryM )
UPD Ibrutinib (Imbruvica®) approved
11/08/2017 15:27:04
(LoweryM )
UPD Ibrutinib (Imbruvica®) updtaed
09/08/2017 16:48:26
(DavidS )
UPD Ibrutinib Published from Draft Mode
26/04/2017 10:25:58
(LoweryM )
LDL Link Added : NICE TA429: Ibrutinib for previously treated chronic lymphocytic leukaemia and untreated chronic lymphocytic leukaemia with 17p deletion or TP53 mutation : https://www.nice.org.uk/guidance/ta429
24/04/2017 13:44:27
(DavidS )
UPD Ibrutinib (Imbruvica®) Approved by NICE (TA429)
24/04/2017 13:43:56
(DavidS )
UPD Status Changed to | Visible | Published
24/04/2017 13:42:11
(DavidS )
UPD Status Changed to | Hidden | Published
22/03/2017 15:10:44
(DavidS )

 

 
netFormulary